`Gleevec` Is Ready to Go!.
June. 26, 2001 09:27.
.
The remedy for the chronic Myelongenous Leukemia (CML) patients, Gleevec, is packaged in a drug manufacture in Ansan, Kyonggi. This drug, developed by Novartis Pharmaceuticals in Swiss, will sell to the Korean patients from early next month.
The remedy for the chronic Myelongenous Leukemia (CML) patients, Gleevec, is packaged in a drug manufacture in Ansan, Kyonggi. This drug, developed by Novartis Pharmaceuticals in Swiss, will sell to the Korean patients from early next month.